DIRAS3 and non-small cell lung carcinoma: We adopted A549 cells or H520 cells to investigate the relationship between DIRAS3 and NSCLC and uncovered the inhibitory effect of DIRAS3 over-expression on cell migration and invasion, highlighting DIRAS3 as an effective target for the treatment of NSCLC.